Indofarma Financial Statements From 2010 to 2024
| INAF Stock | IDR 126.00 0.00 0.00% |
Check Indofarma Tbk financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Indofarma Tbk's main balance sheet or income statement drivers, such as , as well as many indicators such as . Indofarma financial statements analysis is a perfect complement when working with Indofarma Tbk Valuation or Volatility modules.
Indofarma |
Indofarma Tbk Company Profit Margin Analysis
Indofarma Tbk's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Indofarma Tbk Profit Margin | (0.1) % |
Most of Indofarma Tbk's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Indofarma Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Indofarma Tbk has a Profit Margin of -0.0968%. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The profit margin for all Indonesia stocks is notably higher than that of the company.
Indofarma Tbk Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Indofarma Tbk's current stock value. Our valuation model uses many indicators to compare Indofarma Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Indofarma Tbk competition to find correlations between indicators driving Indofarma Tbk's intrinsic value. More Info.Indofarma Tbk is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indofarma Tbk's earnings, one of the primary drivers of an investment's value.About Indofarma Tbk Financial Statements
Indofarma Tbk investors utilize fundamental indicators, such as revenue or net income, to predict how Indofarma Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.